Barriers to optimal care and strategies to promote safe and optimal management of sick young infants during the COVID-19 pandemic: A multi-country formative research study
暂无分享,去创建一个
K. Edmond | L. Muhe | R. Khanam | A. Baqui | J. Applegate | Salahuddin Ahmed | M. Shahidullah | S. Mazumder | Vishwajeet Kumar | Aarti Kumar | S. Yoshida | R. Bahl | N. Bhandari | D. Hailemariam | R. Wammanda | Y. Rao | I. Nisar | F. Jehan | Y. Nisar | S. Qazi | Nivedita Roy | Benazir Baloch | Dorka Woldesenbet | V. P. Singh | A. Estifanos | Solomie Jebessa | N. Goyal | A. Mekasha | Shuchita Gupta | M. Uddin | P. Singh | Temsunaro Rongsen-Chandola | Nigussie Assefa Kassaw | A. Roy | Laila Hassan | E. Anyebe | H. Mehrotra | Nudrat Farheen | Maryam Mansoor | Priyanka Adhikary | Kiran Lalani | S. Qaiser | Rasheda Jennifer Abdullah H Arunangshu Dutta Salahuddin Ma Khanam Applegate Baqui Roy Ahmed Uddin Sh | Vinod Sangal | Rupa Dalmiya Singh | A. Arya | Ishakau Hassan | Dania Mushtaq
[1] S. Cousens,et al. Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals , 2021, The Lancet. Child & adolescent health.
[2] M. Abera,et al. Implementation research on management of sick young infants with possible serious bacterial infection when referral is not possible in Jimma Zone, Ethiopia: Challenges and solutions , 2021, PloS one.
[3] R. Mukhopadhyay,et al. Lessons from implementation research on community management of Possible Serious Bacterial Infection (PSBI) in young infants (0-59 days), when the referral is not feasible in Palwal district of Haryana, India , 2021, PloS one.
[4] F. Esamai,et al. Clinical signs of possible serious infection and associated mortality among young infants presenting at first-level health facilities , 2021, PloS one.
[5] C. S. Wesseh,et al. Disruptions in maternal and child health service utilization during COVID-19: analysis from eight sub-Saharan African countries , 2021, Health policy and planning.
[6] A. Ayede,et al. Management of possible serious bacterial infection in young infants where referral is not possible in the context of existing health system structure in Ibadan, South-west Nigeria , 2021, PloS one.
[7] J. Lawn,et al. Small and sick newborn care during the COVID-19 pandemic: global survey and thematic analysis of healthcare providers’ voices and experiences , 2021, BMJ Global Health.
[8] W. Terefe,et al. Innovative approach for potential scale-up to jump-start simplified management of sick young infants with possible serious bacterial infection when a referral is not feasible: Findings from implementation research. , 2021, PloS one.
[9] M. Bhan,et al. Management of possible serious bacterial infection in young infants closer to home when referral is not feasible: Lessons from implementation research in Himachal Pradesh, India , 2020, PloS one.
[10] S. Soofi,et al. Evaluating implementation of “management of Possible Serious Bacterial Infection (PSBI) when referral is not feasible” in primary health care facilities in Sindh province, Pakistan , 2020, PloS one.
[11] Rutuja Patil,et al. Feasibility of implementation of simplified management of young infants with possible serious bacterial infection when referral is not feasible in tribal areas of Pune district, Maharashtra, India , 2020, PloS one.
[12] G. Agarwal,et al. Identification and management of young infants with possible serious bacterial infection where referral was not feasible in rural Lucknow district of Uttar Pradesh, India: An implementation research , 2020, PloS one.
[13] N. Walker,et al. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study , 2020, The Lancet Global Health.
[14] M. Shahidullah,et al. Managing possible serious bacterial infection of young infants where referral is not possible: Lessons from the early implementation experience in Kushtia District learning laboratory, Bangladesh , 2020, PloS one.
[15] A. Nakimuli,et al. Voices from the frontline: findings from a thematic analysis of a rapid online global survey of maternal and newborn health professionals facing the COVID-19 pandemic , 2020, BMJ Global Health.
[16] A. Baqui,et al. Provider performance and facility readiness for managing infections in young infants in primary care facilities in rural Bangladesh , 2020, PloS one.
[17] A. Baqui,et al. Caregiver acceptability of the guidelines for managing young infants with possible serious bacterial infections (PSBI) in primary care facilities in rural Bangladesh , 2020, PloS one.
[18] S. Qazi,et al. Feasibility of implementing the World Health Organization case management guideline for possible serious bacterial infection among young infants in Ntcheu district, Malawi , 2020, PloS one.
[19] R. Bahl,et al. Implementation of the WHO guideline on treatment of young infants with signs of possible serious bacterial infection when hospital referral is not feasible in rural Zaria, Nigeria: Challenges and solutions , 2020, PloS one.
[20] A. Baqui,et al. Early implementation of guidelines for managing young infants with possible serious bacterial infection in Bangladesh , 2019, BMJ Global Health.
[21] Julie M. Herlihy,et al. Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study , 2019 .
[22] S. Cousens,et al. Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial , 2016, The Lancet. Global health.
[23] F. Esamai,et al. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial , 2015, The Lancet.
[24] F. Esamai,et al. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial , 2015, The Lancet.
[25] S. Cousens,et al. Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open-label, equivalence trial. , 2015, The Lancet. Global health.